AAAAAA

   
Results: 1-25 | 26-40
Results: 1-25/40
Waldenstrom macroglobulinemia - Development of diagnostic criteria and identification of prognostic factors
Authors: Owen, RG Barrans, SL Richards, SJ O'Connor, SJM Child, JA Parapia, LA Morgan, GJ Jack, AS
Citation: Rg. Owen et al., Waldenstrom macroglobulinemia - Development of diagnostic criteria and identification of prognostic factors, AM J CLIN P, 116(3), 2001, pp. 420-428
NAT2 acetylator genotypes confer no effect on the risk of developing adultacute leukemia: A case-control study
Authors: Rollinson, S Roddam, P Willett, E Roman, E Cartwright, R Jack, A Morgan, GJ
Citation: S. Rollinson et al., NAT2 acetylator genotypes confer no effect on the risk of developing adultacute leukemia: A case-control study, CANC EPID B, 10(5), 2001, pp. 567-568
The simulation of electron diffusion in solids at finite temperature
Authors: Carter, J Michez, LA Hickey, BJ Morgan, GJ
Citation: J. Carter et al., The simulation of electron diffusion in solids at finite temperature, MODEL SIM M, 9(1), 2001, pp. 37-45
Autoimmune thrombocytopenia in Waldenstrom's macroglobulinemia
Authors: Owen, RG Lubenko, A Savage, J Parapia, LA Jack, AS Morgan, GJ
Citation: Rg. Owen et al., Autoimmune thrombocytopenia in Waldenstrom's macroglobulinemia, AM J HEMAT, 66(2), 2001, pp. 116-119
Treatment of elderly patients with nabumetone or diclofenac - Gastrointestinal safety profile
Authors: Morgan, GJ Kaine, J DeLapp, R Palmer, R
Citation: Gj. Morgan et al., Treatment of elderly patients with nabumetone or diclofenac - Gastrointestinal safety profile, J CLIN GAST, 32(4), 2001, pp. 310-314
Bacteriophage biology and Kenneth Schaffner's rendition of developmentalism
Authors: Morgan, GJ
Citation: Gj. Morgan, Bacteriophage biology and Kenneth Schaffner's rendition of developmentalism, BIOL PHILOS, 16(1), 2001, pp. 85-92
Karyotype and age in acute myeloid leukemia. Are they linked?
Authors: Moorman, AV Roman, E Willett, EV Dovey, GJ Cartwright, RA Morgan, GJ
Citation: Av. Moorman et al., Karyotype and age in acute myeloid leukemia. Are they linked?, CANC GENET, 126(2), 2001, pp. 155-161
Basic electron transport
Authors: Hickey, BJ Morgan, GJ Howson, MA
Citation: Bj. Hickey et al., Basic electron transport, LECT N PHYS, 569, 2001, pp. 52-70
Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia
Authors: Allan, JM Wild, CP Rollinson, S Willett, EV Moorman, AV Dovey, GJ Roddam, PL Roman, E Cartwright, RA Morgan, GJ
Citation: Jm. Allan et al., Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia, P NAS US, 98(20), 2001, pp. 11592-11597
Analysis of CD34(+) cell subsets in stem cell harvests can more reliably predict rapidity and durability of engraftment than total CD34(+) cell dose,but steady state levels do not correlate with bone marrow reserve
Authors: Pratt, G Rawstron, AC English, AE Johnson, RJ Jack, AS Morgan, GJ Smith, GM
Citation: G. Pratt et al., Analysis of CD34(+) cell subsets in stem cell harvests can more reliably predict rapidity and durability of engraftment than total CD34(+) cell dose,but steady state levels do not correlate with bone marrow reserve, BR J HAEM, 114(4), 2001, pp. 937-943
In multiple myeloma, only a single stage of neoplastic plasma cell differentiation can be identified by VLA-5 and CD45 expression
Authors: Rawstron, AC Barrans, SL Blythe, D English, A Richards, SJ Fenton, JAL Davies, FE Child, JA Jack, AS Morgan, GJ
Citation: Ac. Rawstron et al., In multiple myeloma, only a single stage of neoplastic plasma cell differentiation can be identified by VLA-5 and CD45 expression, BR J HAEM, 113(3), 2001, pp. 794-802
The impact of attaining a minimal disease state after high-dose melphalan and autologous transplantation for multiple myeloma
Authors: Davies, FE Forsyth, PD Rawstron, AC Owen, RG Pratt, G Evans, PAS Richards, SJ Drayson, M Smith, GM Selby, PJ Child, JA Morgan, GJ
Citation: Fe. Davies et al., The impact of attaining a minimal disease state after high-dose melphalan and autologous transplantation for multiple myeloma, BR J HAEM, 112(3), 2001, pp. 814-819
Insertional events as well as translocations may arise during aberrant immunoglobulin switch recombination in a patient with multiple myeloma
Authors: Pratt, G Fenton, JAL Davies, FE Rawstron, AC Richards, SJ Collins, JE Owen, RG Jack, AS Smith, GM Morgan, GJ
Citation: G. Pratt et al., Insertional events as well as translocations may arise during aberrant immunoglobulin switch recombination in a patient with multiple myeloma, BR J HAEM, 112(2), 2001, pp. 388-391
Interleukin 6, tumour necrosis factor alpha and lymphotoxin polymorphisms in monoclonal gammopathy of uncertain significance and multiple myeloma
Authors: Dring, AM Davies, FE Rollinson, SJ Roddam, PL Rawstron, AC Child, JA Jack, AS Morgan, GJ
Citation: Am. Dring et al., Interleukin 6, tumour necrosis factor alpha and lymphotoxin polymorphisms in monoclonal gammopathy of uncertain significance and multiple myeloma, BR J HAEM, 112(1), 2001, pp. 249-250
Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome andcan be used to optimize therapy
Authors: Rawstron, AC Kennedy, B Evans, PAS Davies, FE Richards, SJ Haynes, AP Russell, NH Hale, G Morgan, GJ Jack, AS Hillmen, P
Citation: Ac. Rawstron et al., Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome andcan be used to optimize therapy, BLOOD, 98(1), 2001, pp. 29-35
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma
Authors: Davies, FE Raje, N Hideshima, T Lentzsch, S Young, G Tai, YT Lin, B Podar, K Gupta, D Chauhan, D Treon, SP Richardson, PG Schlossman, RL Morgan, GJ Muller, GW Stirling, DI Anderson, KC
Citation: Fe. Davies et al., Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma, BLOOD, 98(1), 2001, pp. 210-216
An analysis of the effect of chronic GvHD on relapse and survival following allogeneic PBSC transplantation
Authors: Miflin, G Russell, NH Franklin, I Cook, G Milligan, DW Hutchinson, RM Potter, MN Morgan, GJ Pagliuca, A Marsh, J Bell, A
Citation: G. Miflin et al., An analysis of the effect of chronic GvHD on relapse and survival following allogeneic PBSC transplantation, CYTOTHERAPY, 2(6), 2000, pp. 423-428
The relationship between typical and atypical B-cell chronic lymphocytic leukemia - A comparative genomic hybridization-based study
Authors: O'Connor, SJM Su'ut, L Morgan, GJ Jack, AS
Citation: Sjm. O'Connor et al., The relationship between typical and atypical B-cell chronic lymphocytic leukemia - A comparative genomic hybridization-based study, AM J CLIN P, 114(3), 2000, pp. 448-458
FLUDAP: Salvage chemotherapy for relapsed/refractory aggressive non-Hodgkin's lymphoma
Authors: Child, JA Johnson, SA Rule, S Smith, GM Morgan, GJ Johnson, PWM Prentice, AG Tollerfield, SM Wareham, E
Citation: Ja. Child et al., FLUDAP: Salvage chemotherapy for relapsed/refractory aggressive non-Hodgkin's lymphoma, LEUK LYMPH, 37(3-4), 2000, pp. 309-317
Poor metabolizers at the cytochrome P450 2D6 and 2C19 loci are at increased risk of developing adult acute leukaemia
Authors: Roddam, PL Rollinson, S Kane, E Roman, E Moorman, A Cartwright, R Morgan, GJ
Citation: Pl. Roddam et al., Poor metabolizers at the cytochrome P450 2D6 and 2C19 loci are at increased risk of developing adult acute leukaemia, PHARMACOGEN, 10(7), 2000, pp. 605-615
High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment
Authors: Davies, FE Rollinson, SJ Rawstron, AC Roman, E Richards, S Drayson, M Child, JA Morgan, GJ
Citation: Fe. Davies et al., High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment, J CL ONCOL, 18(15), 2000, pp. 2843-2851
Nabumetone induced pseudoporphyria in childhood - Dr. Morgan replies
Authors: Morgan, GJ
Citation: Gj. Morgan, Nabumetone induced pseudoporphyria in childhood - Dr. Morgan replies, J RHEUMATOL, 27(7), 2000, pp. 1818-1818
Positive and negative selection to reduce tumour contamination in peripheral blood stem cell harvests
Authors: Davies, FE Rawstron, AC Pratt, G Coupe, R Clarke, D Lubenko, A Short, K Perren, TJ Selby, PJ MacLennan, S Major, K Woodhead, V Robinson, F Child, JA Smith, GM Johnson, PWM Morgan, GJ
Citation: Fe. Davies et al., Positive and negative selection to reduce tumour contamination in peripheral blood stem cell harvests, HEMATOL ONC, 18(3), 2000, pp. 111-120
Waldenstrom's macroglobulinaemia: Laboratory diagnosis and treatment
Authors: Owen, RG Johnson, SA Morgan, GJ
Citation: Rg. Owen et al., Waldenstrom's macroglobulinaemia: Laboratory diagnosis and treatment, HEMATOL ONC, 18(2), 2000, pp. 41-49
Polymorphic variation within the glutathione S-transferase genes and risk of adult acute leukaemia
Authors: Rollinson, S Roddam, P Kane, E Roman, E Cartwright, R Jack, A Morgan, GJ
Citation: S. Rollinson et al., Polymorphic variation within the glutathione S-transferase genes and risk of adult acute leukaemia, CARCINOGENE, 21(1), 2000, pp. 43-47
Risultati: 1-25 | 26-40